On November 16, 2026, the Centers for Medicare & Medicaid Services (CMS) released its “Comprehensive Regulations to Uncover Suspicious Healthcare” (CRUSH) proposed rule. Aimed at strengthening program integrity oversight across Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Health Insurance Marketplace, the proposal builds on a February 2026 request for information and on the Administration’s broader anti-fraud initiatives. The proposed rule covers a wide range of topics, including provider and supplier enrollment, Medicare Advantage (MA) and Part D oversight, Medicaid and CHIP program integrity and eligibility oversight, and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers.
Several proposals would affect providers, suppliers, and the organizations that invest in or contract with them. For Medicare enrollment, CMS proposes to require that all providers and suppliers report any change in enrollment information within 30 days, shortening the current deadline of up to 90 days for certain changes. CMS also proposes to add a new ground for denial or revocation where the identity of a domestic or foreign owner, managing employee, officer, director, or other affiliated party cannot be verified or CMS determines the individual poses an undue risk of fraud, waste, and abuse.
In Medicaid and CHIP, CMS proposes broader grounds for denying or terminating enrollment that mirror Medicare’s (including felony convictions and revocations for abusive billing or prescribing), expanded disclosure of owners, managing employees, and adverse legal actions, mandatory collection and use of National Provider Identifiers (NPIs) across all eligible provider types, monthly state reporting of denials and terminations, and a new 60-day self-reporting and return requirement for Medicaid fee-for-service overpayments. Under the proposed rule, state Medicaid and CHIP programs could also suspend payments based on credible allegations of fraud determinations made by CMS or another federal agency. Organizations with layered ownership structures, frequent ownership or management changes, or multistate Medicaid participation should expect greater compliance burden and diligence scrutiny, along with a higher risk of payment suspension and enrollment actions.
In MA, CMS proposes to require eligible providers and suppliers billing MA plans to enroll in Original, fee-for-service Medicare and to mandate that MA organizations and Part D sponsors report fraud, waste, and abuse referrals to CMS. For DMEPOS suppliers, CMS proposes to expand its prohibition on unsolicited beneficiary contact to text messages, social media direct messages, email without an opt-out, and door-to-door solicitation, make explicit that the prohibition reaches third-party agents such as marketing firms, broaden disclosure of associated entities, and tighten surety bond requirements.
Taken together, the proposals reflect a shift toward front-end screening, proactive detection of potential fraud, waste, or abuse, and earlier enforcement. Because most provisions would take effect 60 days after publication of a final rule unless otherwise specified, stakeholders should assess their exposure now and consider commenting on the feasibility of the proposed timelines and on the scope of the proposed enforcement rules. Comments are due January 19, 2027.
Recent Comments